CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Cognitive Behavioral Therapy +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00183768
NCT00183768Phase 3Completed
CompareCT.gov

Antidepressant Treatment to Reduce HIV Risk Among IDUs

Butler Hospital·interventional·Posted Sep 16, 2005·Updated Aug 22, 2013

In Brief

A Phase 3 clinical trial evaluating Cognitive Behavioral Therapy and Psychopharmacology for HIV Infections and 2 related conditions. Completed, across 1 site.

Detailed Summary

This study will evaluate the effectiveness of combining cognitive behavioral therapy (CBT) and antidepressants in reducing HIV risk behavior and drug relapse rates in depressed intravenous drug users.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections, Depression, Substance-Related Disorders
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 3CompletedFinished
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartSep 1, 1999
Study CompletionFeb 1, 2003
TodayJul 2, 2026
Posted 20.8 years ago

Interventions

Cognitive Behavioral Therapybehavioral

Psychopharmacologybehavioral